Trial intelligence / Profile preview

Prophylactic Antibiotics in Laparoscopic Cholecystectomy

NCT04726046Phase 1Completed

Sponsor
Jeonbuk National University Hospital
Start
Apr 2014
Primary completion
Aug 2015
Modality
Small Molecules
01

Overview

Phase 1, randomised, open-label trial of cefotetan in cholecystitis (2 arms), sponsored by Jeonbuk National University Hospital. Primary endpoint: Surgical complication at 30 days. Started Apr 2014; status: completed.

02

Drugs

cefotetan
03

Conditions

cholecystitis

Beyond the preview

Go deeper on NCT04726046.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04726046.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call